新検索ページはこちら
ログイン
お問い合わせ
（旧版）前立腺癌診療ガイドライン 2006年版
書誌情報
第3章 治療総論
参考文献
9 緩和医療 ＊この項の文献番号は、「第8章緩和医療」の文献番号と対応しています。
| 1） | Smith JA, Jr., Soloway MS, Young MJ. Complications of advanced prostate cancer. Urology. 1999;54（6A Suppl）:8-14. |
| 2） | Scher HI, Chung LW. Bone metastases:improving the therapeutic index. Semin Oncol. 1994;21（5）:630-56. |
| 3） | 日本緩和医療学会，がん疼痛治療ガイドライン作成委員会．Evidence-Based Medicine に則ったがん疼痛治療ガイドライン．真興交易;2000． |
| 4） | Arcangeli G, Giovinazzo G, Saracino B, et al. Radiation therapy in the management of symptomatic bone metastases:the effect of total dose and histology on pain relief and response duration. Int J Radiat Oncol Biol Phys. 1998;42（5）:1119-26. |
| 5） | Bolger JJ, Dearnaley DP, Kirk D, et al. Strontium-89（Metastron）versus external beam radiotherapy in patients with painful bone metastases secondary to prostatic cancer:preliminary report of a multicenter trial. UK Metastron Investigators Group . Semin Oncol. 1993;20（3 Suppl 2）:32-3. |
| 6） | Quilty PM, Kirk D, Bolger JJ, et al. A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer. Radiother Oncol. 1994;31（1）:33-40. |
| 7） | Saad F, Gleason DM, Murray R, et al. A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma. J Natl Cancer Inst. 2002;94（19）:1458-68. |
| 8） | Ross JR, Saunders Y, Edmonds PM, et al. Systematic review of role of bisphosphonates on skeletal morbidity in metastatic cancer. BMJ. 2003;327（7413）:469. |
| 9） | Sorensen S, Helweg-Larsen S, Mouridsen H, et al. Effect of high-dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy:a randomised trial. Eur J Cancer. 1994;30A（1）:22-7. |
| 10） | Young RF, Post EM, King GA. Treatment of spinal epidural metastases. Randomized prospective comparison of laminectomy and radiotherapy. J Neurosurg. 1980;53（6）:741-8. |
| 11） | Crain DS, Amling CL, Kane CJ. Palliative transurethral prostate resection for bladder outlet obstruction in patients with locally advanced prostate cancer. J Urol. 2004;171:668-71. |
| 12） | Kraus PA, Lytton B, Weiss RM, Prosnitz LR. Radiation therapy for local palliative treatment of prostatic cancer. J Urol. 1972;108（4）:612-4. |
| 13） | Oefelein MG. Prognostic significance of obstructive uropathy in advanced prostate cancer. Urology. 2004;63（6）:1117-21. |
| 14） | Watkinson AF, A'Hern RP, Jones A, et al. The role of percutaneous nephrostomy in malignant urinary tract obstruction. Clin Radiol. 1993;47（1）:32-5. |
| 15） | Docimo SG, Dewolf WC. High failure rate of indwelling ureteral stents in patients with extrinsic obstruction:experience at 2 institutions. J Urol. 1989;142:277-9. |
